EXAI Exscientia Ltd ADRs

Exscientia Limited, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. It offers end-to-end solution of artificial intelligence and technologies for target identification, drug candidate design, translational models, and patient selection. Its platform enables to design candidate drug molecules that have progressed into clinical trials, as well as to provide patients with potentially drug therapies through AI guided assessment. The company is based in Oxford, the United Kingdom. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$11.13  -1.39 (-11.10%)
As of 06/28/2022 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  
IPO date:  05/17/2017
Outstanding shares:  117,901,684
Average volume:  196,266
Market cap:   $1,615,253,071
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   2.92
PS ratio:   42.57
Return on equity:   -6.68%
Net income %:   -169.39%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy